Laurie Toich, Assistant Editor

Study challenges previous findings that suggest night shift work increases the risk of breast cancer.

State insurance departments begin to align Affordable Care Act tips with CMS efforts.

Top news of the day from across the healthcare landscape.

Xtandi’s revised label will include results a study showing improve progression-free survival in prostate cancer.

Experimental treatment uses mRNA expression from tumors to identify responders.

The use of big data has led to discoveries about drug interactions that can result in a fatal heart condition.

No change in prostate-specific antigen tests for cancer was found before and after new screening guidelines.

Top news of the day from across the healthcare landscape.

Women outperformed men in cognitive impairment tests indicative of conditions such as Alzheimer’s disease.

Researchers were able to crystalize a protein that plays a role in nicotine addiction, which may provide a new treatment target to end tobacco cravings and treat multiple diseases, including Alzheimer's disease.

FDA awards $23 million to 21 clinical trials of treatments and devices for rare diseases.

Inflectra is the first biosimilar monoclonal antibody approved by the FDA.

Celgene and Agios will collaborate with a technology company to improve diagnostics for patients with acute myeloid leukemia.

Rolofylline could prevent clumps of Tau protein associated with certain cognitive disorders.

Efficacy and safety data shows encouraging results for rucaparib in BRCA-mutation ovarian cancer.

Top news of the day from across the healthcare landscape.

Efficacy and safety data shows encouraging results for rucaparib in BRCA-mutation ovarian cancer.

Each year, the federal government implements certain strategies to increase enrollment in Affordable Care Act health plans.

CMS to conduct outreach programs for uninsured individuals to reduce the healthcare cost burden.

Inhibiting Ran-GTP was associated with reversing and preventing treatment-resistant cancers.

Top news of the day from across the healthcare landscape.

Understanding the structure of the nicotinic receptor can lead to treatments for nicotine addiction and diseases such as Alzheimer’s disease.

Major pathological tumor regression was experienced by 40% of patients receiving neoadjuvant immunotherapy before resection.

Nivolumab prior to tumor resection found safe in patients with early non-small cell lung cancer.

Findings could translate into preventative treatments for Alzheimer’s and Parkinson’s diseases.

Top news of the day from across the healthcare landscape.

A diagnostic blood test could diagnose patients in early stages of non-alcoholic fatty liver disease.

Researchers prove the accuracy of tau PET imagining for Alzheimer’s disease.

Only 19% of companies publically share compassionate use policies on their websites.

Proposition 61 would force state agencies to pay the same price for drugs paid by the US Department of Veterans Affairs.